98%
921
2 minutes
20
Coronary microvascular dysfunction (CMD) is a high-risk factor for numerous cardiovascular events, and there is an increasing focus on the diagnosis and treatment of CMD itself or its association with cardiovascular diseases. However, some evidences suggest potential associations between CMD and multiple extracardiac pathologies, such as cerebrovascular, renal, pulmonary, retinal, hepatic, immune system diseases, and cancer. A shared pathological mechanism may underlie these connections, yet the relationship between CMD and other organs and systemic diseases remains unclear. Therefore, this review comprehensively assesses the current evidence base for the interplay between CMD and a range of systemic diseases, highlighting the need for a more integrated diagnostic and therapeutic approach.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12380738 | PMC |
http://dx.doi.org/10.3389/fcvm.2025.1616332 | DOI Listing |
Cureus
August 2025
Rheumatology, King's College Hospital London, Dubai, ARE.
Systemic sclerosis (SSc) is an autoimmune rheumatic disease marked by excessive extracellular matrix deposition, causing fibrosis, endothelial dysfunction, and microvascular injury. There are two major types of SSc, limited and diffuse. SSc can affect any organ, leading to dysfunction and failure.
View Article and Find Full Text PDFFront Pharmacol
August 2025
Department of Cardiology, 920th Hospital of Joint Logistics Support Force of PLA, Kunming, China.
Background And Objectives: High-altitude hypoxia is known to impair cardiac microvascular function, a pathophysiological state recognized as coronary microvascular disease (CMVD). This study aimed to investigate the independent association between serum potassium levels and the risk of developing CMVD, after controlling for traditional cardiovascular risk factors such as hypertension, dyslipidemia, and smoking.
Methods: This case-control study enrolled 1,175 trainees with long-term exposure to high altitude (≥3,000 m), comprising 235 patients with CMVD (cases) and 940 healthy controls.
Eur Heart J Case Rep
September 2025
Department of Cardiology, Gifu Prefectural General Medical Center, 4-6-1, Noisshiki, Gifu 500-8717, Japan.
Eur J Heart Fail
September 2025
Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Eur J Heart Fail
September 2025
Zigong Maternal and Child Health Care Hospital, Zigong, China.